PROVIDER PROFILE · NPI 1104874338

Dacia GerstFNP

PRESCRIBING · PART D · 2024
Total Rx claims
30
Beneficiaries
—
Total drug cost
$17K
Distinct drugs
2
Brand share
100.0%
Top prescribed drugs
Apixaban18 claims
Empagliflozin12 claims
QUALITY · MIPS · 2024
Final MIPS score
82.0
Quality
55.9
Cost
72.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.29%
Group
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

Hospital
Hospital